Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Current Opinion in Virology|June 19, 2026
Combination adjuvants: clinical value and mechanisms of actionNatacha Madelon, Arnaud M DidierlaurentExpert Review of Vaccines|March 3, 2012
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsionNathalie Garçon, David W Vaughn, Arnaud M DidierlaurentImmunity & Ageing : I & A|November 4, 2025
Ageing with HIV-1: immunological challenges for effective vaccinationPauline Saint-Charles, Arnaud M Didierlaurent, Victor AppaySeminars in Immunology|May 27, 2018
Correlates of adjuvanticity: A review on adjuvants in licensed vaccinesGiuseppe Del Giudice, Rino Rappuoli, Arnaud M DidierlaurentCurrent Opinion in Immunology|July 30, 2017
Towards an evidence based approach for the development of adjuvanted vaccinesDerek T O'Hagan, Leonard R Friedland, Emmanuel Hanon, et al.Vaccine|April 3, 2022
Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adultsWivine Burny, Caroline Hervé, Magalie Caubet, et al.NPJ Vaccines|October 5, 2019
The how's and what's of vaccine reactogenicityCaroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice, et al.Expert Review of Vaccines|July 25, 2016
Adjuvant system AS01: helping to overcome the challenges of modern vaccinesArnaud M Didierlaurent, Béatrice Laupèze, Alberta Di Pasquale, et al.European Journal of Immunology|September 7, 2019
Toll-like receptor 4 signaling in hematopoietic-lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01Laurye Van Maele, Delphine Fougeron, Delphine Cayet, et al.The Journal of Infectious Diseases|October 18, 2021
Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster VaccineAndrea Callegaro, Wivine Burny, Caroline Hervé, et al.Pageof 6